Works matching AU McBride, Jodi L.

Results: 14

In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using 11C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1581, doi. 10.2967/jnumed.123.265569

By:

Bertoglio, Daniele;
Weiss, Alison R.;
Liguore, William;
Martin, Lauren Drew;
Hobbs, Theodore;
Templon, John;
Srinivasan, Sathya;
Dominguez, Celia;
Munoz-Sanjuan, Ignacio;
Khetarpal, Vinod;
Verhaeghe, Jeroen;
Staelens, Steven;
Link, Jeanne;
Liu, Longbin;
Bard, Jonathan A.;
McBride, Jodi L.

Publication type:

Article

Reduced D2/D3 Receptor Binding and Glucose Metabolism in a Macaque Model of Huntington's Disease.

Published in:

Movement Disorders, 2023, v. 38, n. 1, p. 143, doi. 10.1002/mds.29271

By:

Weiss, Alison R.;
Bertoglio, Daniele;
Liguore, William A.;
Brandon, Kristin;
Templon, John;
Link, Jeanne;
McBride, Jodi L.

Publication type:

Article

Transvascular delivery of small interfering RNA to the central nervous system.

Published in:

Nature, 2007, v. 448, n. 7149, p. 39, doi. 10.1038/nature05901

By:

Kumar, Priti;
Wu, Haoquan;
McBride, Jodi L.;
Kyeong-Eun Jung;
Moon Hee Kim;
Davidson, Beverly L.;
Sang Kyung Lee;
Shankar, Premlata;
Manjunath, N.

Publication type:

Article

Restoring Acid-Sensing Ion Channel-1a in the Amygdala of Knock-Out Mice Rescues Fear Memory But Not Unconditioned Fear Responses.

Published in:

Journal of Neuroscience, 2008, v. 28, n. 51, p. 13737, doi. 10.1523/JNEUROSCI.3907-08.2008

By:

Coryell, Matthew W.;
Wunsch, Amanda M.;
Haenfler, Jill M.;
Allen, Jason E.;
McBride, Jodi L.;
Davidson, Beverly L.;
Wemmie, John A.

Publication type:

Article

Intrajugular Vein Delivery of AAV9-RNAi Prevents Neuropathological Changes and Weight Loss in Huntington's Disease Mice.

Published in:

Molecular Therapy, 2014, v. 22, n. 4, p. 797, doi. 10.1038/mt.2013.289

By:

Dufour, Brett D;
Smith, Catherine A;
Clark, Randall L;
Walker, Timothy R;
McBride, Jodi L

Publication type:

Article

Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease.

Published in:

Molecular Therapy, 2011, v. 19, n. 12, p. 2152, doi. 10.1038/mt.2011.219

By:

McBride, Jodi L;
Pitzer, Mark R;
Boudreau, Ryan L;
Dufour, Brett;
Hobbs, Theodore;
Ojeda, Sergio R;
Davidson, Beverly L

Publication type:

Article

Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice.

Published in:

Molecular Therapy, 2009, v. 17, n. 6, p. 1053, doi. 10.1038/mt.2009.17

By:

Boudreau, Ryan L.;
McBride, Jodi L.;
Martins, Inês;
Shihao Shen;
Yi Xing;
Carter, Barrie J.;
Davidson, Beverly L.

Publication type:

Article

414. Non-Allele Specific RNA Interference in the CAG140 Knock-In Mouse Model of Huntington's Disease.

Published in:

Molecular Therapy, 2006, v. 13, p. S159, doi. 10.1016/j.ymthe.2006.08.478

By:

McBride, Jodi L.;
Harper, Scott Q.;
Staber, Patrick D.;
Martins, Ines H.;
Burstein, Haim;
Peluso, Richard W.;
Polisky, Barry;
Carter, Barrie J.;
Davidson, Beverly L.

Publication type:

Article

Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain.

Published in:

Nucleic Acids Research, 2014, v. 42, n. 21, p. 13315, doi. 10.1093/nar/gku979

By:

Monteys, Alex Mas;
Spengler, Ryan M.;
Dufour, Brett D.;
Wilson, Matt S.;
Oakley, Clayton K.;
Sowada, Matt J.;
McBride, Jodi L.;
Davidson, Beverly L.

Publication type:

Article

A novel rhesus macaque model of Huntington's disease recapitulates key neuropathological changes along with motor and cognitive decline.

Published in:

eLife, 2022, p. 1, doi. 10.7554/eLife.77568

By:

Weiss, Alison R.;
Liguore, William A.;
Brandon, Kristin;
Xiaojie Wang;
Zheng Liu;
Domire, Jacqueline S.;
Button, Dana;
Srinivasan, Sathya;
Kroenke, Christopher D.;
McBride, Jodi L.

Publication type:

Article

Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63559-7

By:

Weiss, Alison R.;
Liguore, William A.;
Domire, Jacqueline S.;
Button, Dana;
McBride, Jodi L.

Publication type:

Article

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.

Published in:

Brain Communications, 2022, v. 4, n. 6, p. 1, doi. 10.1093/braincomms/fcac309

By:

Caron, Nicholas S.;
Haqqani, Arsalan S.;
Sandhu, Akshdeep;
Aly, Amirah E.;
Black, Hailey Findlay;
Bone, Jeffrey N.;
McBride, Jodi L.;
Abulrob, Abedelnasser;
Stanimirovic, Danica;
Leavitt, Blair R.;
Hayden, Michael R.

Publication type:

Article

Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia.

Published in:

Human Molecular Genetics, 2016, v. 25, n. R1, p. R53, doi. 10.1093/hmg/ddv442

By:

Keiser, Megan S.;
Kordasiewicz, Holly B.;
McBride, Jodi L.

Publication type:

Article

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Published in:

Human Molecular Genetics, 2012, v. 21, n. 2, p. 406, doi. 10.1093/hmg/ddr475

By:

Shirendeb, Ulziibat P.;
Calkins, Marcus J.;
Manczak, Maria;
Anekonda, Vishwanath;
Dufour, Brett;
McBride, Jodi L.;
Mao, Peizhong;
Reddy, P. Hemachandra

Publication type:

Article

Works matching AU McBride, Jodi L.

In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using <sup>11</sup>C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease.

Reduced D<sub>2</sub>/D<sub>3</sub> Receptor Binding and Glucose Metabolism in a Macaque Model of Huntington's Disease.

Transvascular delivery of small interfering RNA to the central nervous system.

Restoring Acid-Sensing Ion Channel-1a in the Amygdala of Knock-Out Mice Rescues Fear Memory But Not Unconditioned Fear Responses.

Intrajugular Vein Delivery of AAV9-RNAi Prevents Neuropathological Changes and Weight Loss in Huntington's Disease Mice.

Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease.

Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice.

414. Non-Allele Specific RNA Interference in the CAG140 Knock-In Mouse Model of Huntington's Disease.

Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain.

A novel rhesus macaque model of Huntington's disease recapitulates key neuropathological changes along with motor and cognitive decline.

Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development.

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.

Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia.

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.